Key result
Black patients with COVID-19 and STEMI had significantly lower odds of invasive management compared to White patients (OR 0.61; 95% CI 0.43-0.85; p=0.004).
Its licence doesn't allow us to show a copy here.
Why the study?
Data were lacking regarding the impact of gender, race, and insurance status on invasive management and inhospital mortality among patients with COVID-19 and STEMI in the United States.
Do gender, race, and insurance status impact the rates of invasive management and inhospital mortality in patients with concurrent COVID-19 and STEMI?
Observational (n=5,990)
Yes
Do gender, race, and insurance status impact the rates of invasive management and inhospital mortality in patients with concurrent COVID-19 and STEMI?
Significant gender and racial disparities exist in the invasive management of STEMI among COVID-19 patients, with women and racial minorities receiving less invasive care.
Signals need for equity protocols in STEMI care; extends disparity research to COVID-19 context.
There is a paucity of data exploring the impact of gender, race, and insurance status on invasive management and inhospital mortality in patients with COVID-19 with ST-elevation myocardial infarction (STEMI) in the United States. The National Inpatient Sample database for the year 2020 was queried to identify all adult hospitalizations with STEMI and concurrent COVID-19. A total of 5,990 patients with COVID-19 with STEMI were identified. Women had 31% lower odds of invasive management and 32% lower odds of coronary revascularization than men. Black patients had lower odds of invasive management (odds ratio [OR] 0.61, 95% confidence interval [CI] 0.43 to 0.85, p = 0.004) than White patients. Black and Asian patients had lower odds of percutaneous coronary intervention (Black: OR 0.55, 95% CI 0.38 to 0.80, p = 0.002; Asian: OR 0.39, 95% CI 0.18 to 0.85, p = 0.018) than White patients. Uninsured patients had higher odds of getting percutaneous coronary intervention (OR 1.78, 95% CI 1.05 to 2.98, p = 0.031) and lower odds of inhospital mortality (OR 0.41, 95% CI 0.19 to 0.89, p = 0.023) than privately insured patients. Patients with out-of-hospital STEMI had 19 times higher odds of invasive management and 80% lower odds of inhospital mortality than inhospital STEMI. In conclusion, we note important gender and racial disparities in invasive management of patients with COVID-19 with STEMI. Surprisingly, uninsured patients had higher revascularization rates and lower mortality than privately insured patients.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2023) conducted an observational in COVID-19 with ST-elevation myocardial infarction (STEMI) (n=5,990). Black race vs. White race was evaluated on Invasive management (OR 0.61, 95% CI 0.43 to 0.85, p=0.004). Black patients with COVID-19 and STEMI had significantly lower odds of invasive management compared to White patients (OR 0.61; 95% CI 0.43-0.85; p=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: